INTRODUCTION TO COVIR
Coronaviruses are named for the spikes that protrude from their surfaces, resembling a crown or the sun’s corona. They can infect both animals and people, and can cause illnesses of the respiratory tract.
At least four types of coronaviruses cause very mild infections every year, like the common cold. Most people get infected with one or more of these viruses at some point in their lives.
Another coronavirus that circulated in China in 2003 caused a more dangerous condition known as Severe Acute Respiratory Syndrome, or SARS. The virus was contained after it had sickened 8,098 people and killed 774.
Middle East Respiratory Syndrome, or MERS, first reported in Saudi Arabia in 2012, is also caused by a coronavirus.
The new virus has been named SARS-CoV-2. The disease it causes is called Covid-19.
How dangerous is it?
It is hard to accurately assess the lethality of a new virus. It appears to be less often fatal than the coronaviruses that caused SARS or MERS, but significantly more so than the seasonal flu. The fatality rate was over 2 percent, in one study. But government scientists have estimated that the real figure could be below 1 percent, roughly the rate occurring in a severe flu season.
About 5 percent of the patients who were hospitalized in China had critical illnesses.
Children seem less likely to be infected with the new coronavirus, while middle-aged and older adults are disproportionately infected.
Men are more likely to die from an infection compared to women, possibly because they produce weaker immune responses and have higher rates of tobacco consumption, Type 2 diabetes and high blood pressure than women, which may increase the risk of complications following an infection.
“This is a pattern we’ve seen with many viral infections of the respiratory tract — men can have worse outcomes,” said Sabra Klein, a scientist who studies sex differences in viral infections and vaccination responses at the Johns Hopkins Bloomberg School of Public Health.
How is the new coronavirus transmitted?
Experts believe that an infected animal may have first transmitted the virus to humans at a market that sold live fish, animals and birds in Wuhan. The market was later shut down and disinfected, making it nearly impossible to investigate which animal may have been the exact origin.
Bats are considered a possible source, because they have evolved to coexist with many viruses, and they were found to be the starting point for SARS. It is also possible that bats transmitted the virus to an intermediate animal, such as pangolins, which are consumed as a delicacy in parts of China, and may have then passed on the virus to humans.
Most respiratory droplets fall to the ground within a few feet. People who are in close contact with those infected, particularly family members and health care workers, may catch the virus this way.
Scientists don’t know how long the new coronavirus can live on surfaces, and preliminary research suggests that hot and humid environments may not slow down the pathogen’s spread. Warm weather does tend to inhibit influenza and milder coronaviruses.
Infected people may be able to pass on the new coronavirus even if they have few obvious symptoms, a study in Germany has found. That’s “bad news,” said Dr. William Schaffner, an expert in infectious diseases at Vanderbilt University Medical Center in Nashville.
When people don’t know they are infected, “they’re up and about, going to work or the gym or to religious services, and breathing on or near other people,” he said. Still, a report by the World Health Organization suggests that asymptomatic cases are rare.
Is there a test for the virus? What is the treatment?
There is a diagnostic test that can determine if you are infected. It was developed by the Centers for Disease Control and Prevention, based on genetic information about the virus provided by the Chinese authorities.
In early February, the C.D.C. sent diagnostic test kits to 200 state laboratories, but some of the kits were flawed and recalled. Now other laboratories are making their own tests. Other countries are using test kits manufactured locally or sent out by the W.H.O.
The C.D.C. announced that anyone who wanted to be tested could, if a doctor approves the request. Private companies, such as LabCorp and Quest Diagnostics, are also rushing to provide tests at various labs across the country, but the supply has yet to meet public demand. Many patients complain that they still cannot get tested.
What symptoms should I look out for?
Symptoms of this infection include fever, cough and difficulty breathing or shortness of breath. The illness causes lung lesions and pneumonia. But milder cases may resemble the flu or a bad cold, making detection difficult.
How can I protect myself?
The best thing you can do to avoid getting infected is to follow the same general guidelines that experts recommend during flu season, because the coronavirus spreads in much the same way. Wash your hands frequently throughout the day. Avoid touching your face, and maintain a distance — at least six feet — from anyone who is coughing or sneezing.
COVIR POWERED BY OCTOPUS ROBORT
The 2019–20 coronavirus pandemic is an ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2).The outbreak was first identified in Wuhan, Hubei, China, in December 2019, and was recognised as a pandemic by the World Health Organization (WHO) on 11 March 2020. As of 22 March, more than 321,000 cases of COVID-19 have been reported in over 180 countries and territories, resulting in more than 13,600 deaths.
About OCTOPUS ROBOTS
is a French public limited company with a board of directors, active for 33 years. Located in CHOLET (49300) France, the company has always been specialized in high technologies (e.g. non-contact measuring systems). In 2012, it moved into the HealthCare sector by developing patented technologies in the area of High Level Disinfection (HLD) on various surfaces, with an innovative airborne disinfection system and sold it through a network of distributors worldwide. Nowadays, OCTOPUS ROBOTS develops and markets mobile, autonomous, smart and modular robots for use in various industries such as agricultural business, defense and surveillance. It is an innovation dedicated for businesses with a unique patented technology (PCT). Its objective is to micro-aerosolize/deliver liquid substances (biocides/sterilant, vaccines, phytosanitary and pest control products…) in the form of a dry fog to treat the whole space by moving the scattering sphere to get as close as possible to the target (efficient to treat large volumes such as public establishments “ERP” – airports, shopping malls, hospitals, etc.)
OCTOPUS ROBOTS is an AgTech and a pioneer company in the field of Biosafety, which has been listed on the stock exchange since March 14, 2018 on the Euronext Paris ACCESS compartment. Website Facebook Twitter LinkedIn YouTube Covir.io is powered by Pagest.environnement SA registered in Geneva Switzerland. Pagest.environnement SA was founded in 2000 ; K : 260 000 CHF and is active since. It is involved in sustainable devlopment projects, environment , green energy and biosecurity . President Jacques Point is graduated from UNI Geneve and operated in green blockchain projects for many years. Website https://covir.io https://octopusrobots.com https://www.facebook.com/octopusrobots https://twitter.com/octopusrobots https://www.linkedin.com/company/octopus-robots https://www.youtube.com/c/octopusrobots
No alt text provided for this image
In 2004 OctopusRobots worked on a surface disinfection solution. In the early 2010s, it created an aerial disinfection system, Biosafety, designed to decontaminate equipment and buildings open to the public, food factories, warehouses and even shopping centers. In 2014 Octopus Robots turned to the poultry production sector, with a range of robots for the decontamination of chicken coops. However, having become Octopus Robots, listed on the Euronext stock market and employing 15 people, the Cholet company never gave up on its primary ambition.
Since the start of the health crisis, people have come to see our robot for disinfecting buildings welcoming the public. We have contacts in France and Italy, and potential customers even came from China a few weeks ago. A return to the original project i.e. the technology of Octopus Robots machines is based on micro-nebulization, namely the creation of a dry mist, with tiny calibrated drops of 12 micrometers in diameter. Without condensation, the principle avoids corrosion. The product used is compatible with electronic and electrical devices. It fits everywhere, in drawers, closets, disinfects fabrics and all surfaces without attacking or damaging them. The machine is very precise because the droplets must not recombine with each other, otherwise they would form moisture. The module, which therefore creates a dry mist, is installed on a remote-controlled and programmable mobile base, and the decontaminating products are compatible with the standards in force. Dispersion tests were carried out in supermarkets. In reality, we are returning to the origin of the Octopus project, because the company's orientation towards disinfection in poultry buildings was almost imposed on us, lack to have met our market.
With Covir we do hope to raise funds and enable faster go to market operations for Octopus Biosafety and its licences.
MISSION
Octopusrobots, a company listed on the stock exchange on Access, filed a patent on February 7, 2017 PCT / FR2017 / 050277 (valid for 20 years i.e. 2037) and is developing a technology for air disinfection (spray) of spaces and surfaces potentially contaminated by viruses e.g. Covid-19, or bacteria. The global containment measures do not allow to classically negotiate "face to face" with Asian, Russian, US customers etc… and the financing being very urgent and important to industrialize quickly it was decided to use digital methods to strengthen the effectiveness of financing implementations and finding resources and solutions outside of conventional financial systems (banks, funds, etc.) In partnership with COVIR.IO operational pre-financing vehicle; Octopusrobots launches the prefinancing of its global portfolio of potential licenses by TOKENIZING ITS LICENSING RIGHTS ON THE TEZOS BLOCKCHAIN.
DECONTAMINATION OF EXTENSIVE BUILDINGS Octopus Biosafety efficiently treats very large volume environments. It can treat oversized premises compare with existing aerosol delivery systems.
OCTOPUSROBOTS & COVIR.IO PRESENT OCTOPUS BIOSAFETY
A robot designed to decontaminate equipment and large buildings such as food storage facilities and food processing plants, airport terminals, shopping malls and any other public buildings. Octopus Biosafety is a mobile, intelligent, fully autonomous and modular robot. Its unique atomization module delivers biocides in aerosolized form (ultramicroscopic particles) while getting away from temperature gradients and air flow issues that may negatively impact disinfection operation. It is a viable solution to fight Covid-19 by decontaminating public places. More at https://octopusrobots.com
BENEFITS
The digitalization of license fees, therefore of intangible assets, enabled by tokenization will allow better liquidity, mutualisation and greater openness of countries or geographic areas under negotiation. It will allow better efficiency enabled by technology, smart contracts which will automate the payment of royalties
COVIR this is a reliable project with excellent characteristics and a unique idea. This is a great project. I appreciate this very much. I am very hopeful for the success.COVIR uses the latest standards of digital wallet management and provide our users with an intuitive layout, powerful and lightning-fast features, and maximum security of funds.COVIR Strong team with a great project. Love to be a part of this movement and wishing a successful to all team members and developers.The most interesting project to date.
I am Very Happy i part "COVIR " Project.
For more info visit :
Website : https://covir.io & https://covir.fr
Octopus Robots : https://octopusrobots.com
Whitepaper : https://covir.fr/wp-content/uploads/2020/03/covir_v2-2.pdf
Telegram : https://t.me/covirio
Twitter : https://twitter.com/Covir_io
Facebook : https://www.facebook.com/CovirIO
Reddit : https://www.reddit.com/r/covir/
Linkedin : https://www.linkedin.com/company/covir-io/
Youtube : https://www.youtube.com/c/OCTOPUSROBOTS
Ann Thread : https://bitcointalk.org/index.php?topic=5243195
Author:
BTT UserName : Sulman326
My Account : https://bitcointalk.org/index.php?action=profile;u=2829891
User ID Tele: @MSarwar180
my addres : tz1SMBY5qPLXjv3q8pjFd827cDQmCZJs4Kac